In a major leap forward for cancer treatment worldwide, scientists in China have developed a highly scalable and cost-effective way to mass-produce powerful immune cells capable of targeting and destroying cancer cells — a development that could help overcome one of the biggest bottlenecks in cancer immunotherapy.
Researchers at the...